CTLT Catalent, Inc: Accounting Value per Share

Catalent, Inc. management is successfully implementing advanced technologies and preparing for a merger with a major fund. The target book value per share on the GURU.Markets chart demonstrates capital dynamics, where 19.53 expresses the latest metric level. Large-scale vaccine production deals are creating synergy, while the sector's independence from macroeconomics makes the asset a reliable defensive tool.

Catalent Inc. (CTLT): Share Book Value from 07/04/2022 to 01/04/2025

catalent.com - analytical breakdowns and key metrics (CTLT)

- price and consensus price forecast:

Price Chart Catalent Pharma Solutions|CTLT - Price Target Chart

- market capitalization data:

Market Valuation Catalent, Inc.|CTLT - Aggregate Business Value

- book capitalization data:

Net Assets per Single Share Catalent|CTLT - Net Asset Value|Market Capitalization to Book Value Ratio catalent.com|CTLT - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital Catalent, Inc.|CTLT - Long-Term Debt to Capital|Short-Term Debt to Equity Catalent|CTLT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Catalent, Inc.

Fundamental company valuation:Catalent Pharma Solutions - CTLT

Catalent, Inc. (CTLT) is scaling high-tech automated sterile fill-finish lines with the implementation of AI control, which requires significant capital expenditures in fixed assets. An analysis of the book value per share allows for tracking the real value of net assets per share, protecting capital from resource degradation and confirming the issuer's fundamental stability through equity dynamics.

Competitors of Catalent, Inc. (CTLT)